nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—TNF—metabolic syndrome X	0.574	0.678	CbGaD
Pomalidomide—PTGS2—metabolic syndrome X	0.272	0.322	CbGaD
Pomalidomide—Thalidomide—TNF—metabolic syndrome X	0.00245	0.441	CrCbGaD
Pomalidomide—Lenalidomide—PTGS2—metabolic syndrome X	0.00194	0.35	CrCbGaD
Pomalidomide—Neuropathy—Metformin—metabolic syndrome X	0.00129	0.0537	CcSEcCtD
Pomalidomide—Thalidomide—PTGS2—metabolic syndrome X	0.00116	0.209	CrCbGaD
Pomalidomide—Pain in extremity—Metformin—metabolic syndrome X	0.000996	0.0415	CcSEcCtD
Pomalidomide—Dehydration—Metformin—metabolic syndrome X	0.000926	0.0386	CcSEcCtD
Pomalidomide—Breast disorder—Metformin—metabolic syndrome X	0.0009	0.0375	CcSEcCtD
Pomalidomide—Nasopharyngitis—Metformin—metabolic syndrome X	0.000891	0.0371	CcSEcCtD
Pomalidomide—Neutropenia—Metformin—metabolic syndrome X	0.000805	0.0336	CcSEcCtD
Pomalidomide—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.0008	0.0334	CcSEcCtD
Pomalidomide—Infestation NOS—Metformin—metabolic syndrome X	0.000767	0.032	CcSEcCtD
Pomalidomide—Infestation—Metformin—metabolic syndrome X	0.000767	0.032	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Metformin—metabolic syndrome X	0.000752	0.0314	CcSEcCtD
Pomalidomide—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000726	0.0303	CcSEcCtD
Pomalidomide—Oedema peripheral—Metformin—metabolic syndrome X	0.000679	0.0283	CcSEcCtD
Pomalidomide—Connective tissue disorder—Metformin—metabolic syndrome X	0.000677	0.0282	CcSEcCtD
Pomalidomide—Cardiac disorder—Metformin—metabolic syndrome X	0.000639	0.0267	CcSEcCtD
Pomalidomide—Angiopathy—Metformin—metabolic syndrome X	0.000625	0.0261	CcSEcCtD
Pomalidomide—Mediastinal disorder—Metformin—metabolic syndrome X	0.000621	0.0259	CcSEcCtD
Pomalidomide—Chills—Metformin—metabolic syndrome X	0.000618	0.0258	CcSEcCtD
Pomalidomide—Malnutrition—Metformin—metabolic syndrome X	0.0006	0.025	CcSEcCtD
Pomalidomide—Muscle spasms—Metformin—metabolic syndrome X	0.000577	0.0241	CcSEcCtD
Pomalidomide—Tremor—Metformin—metabolic syndrome X	0.000562	0.0234	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000507	0.0212	CcSEcCtD
Pomalidomide—Infection—Metformin—metabolic syndrome X	0.000486	0.0203	CcSEcCtD
Pomalidomide—Nervous system disorder—Metformin—metabolic syndrome X	0.00048	0.02	CcSEcCtD
Pomalidomide—Thrombocytopenia—Metformin—metabolic syndrome X	0.000479	0.02	CcSEcCtD
Pomalidomide—Skin disorder—Metformin—metabolic syndrome X	0.000475	0.0198	CcSEcCtD
Pomalidomide—Hyperhidrosis—Metformin—metabolic syndrome X	0.000473	0.0197	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000446	0.0186	CcSEcCtD
Pomalidomide—Dyspnoea—Metformin—metabolic syndrome X	0.000436	0.0182	CcSEcCtD
Pomalidomide—Decreased appetite—Metformin—metabolic syndrome X	0.000425	0.0177	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000423	0.0176	CcSEcCtD
Pomalidomide—Fatigue—Metformin—metabolic syndrome X	0.000422	0.0176	CcSEcCtD
Pomalidomide—Constipation—Metformin—metabolic syndrome X	0.000419	0.0175	CcSEcCtD
Pomalidomide—Feeling abnormal—Metformin—metabolic syndrome X	0.000403	0.0168	CcSEcCtD
Pomalidomide—Asthenia—Metformin—metabolic syndrome X	0.000351	0.0146	CcSEcCtD
Pomalidomide—Pruritus—Metformin—metabolic syndrome X	0.000346	0.0144	CcSEcCtD
Pomalidomide—Diarrhoea—Metformin—metabolic syndrome X	0.000335	0.014	CcSEcCtD
Pomalidomide—Dizziness—Metformin—metabolic syndrome X	0.000324	0.0135	CcSEcCtD
Pomalidomide—Vomiting—Metformin—metabolic syndrome X	0.000311	0.013	CcSEcCtD
Pomalidomide—Rash—Metformin—metabolic syndrome X	0.000309	0.0129	CcSEcCtD
Pomalidomide—Dermatitis—Metformin—metabolic syndrome X	0.000308	0.0129	CcSEcCtD
Pomalidomide—Headache—Metformin—metabolic syndrome X	0.000307	0.0128	CcSEcCtD
Pomalidomide—Nausea—Metformin—metabolic syndrome X	0.000291	0.0121	CcSEcCtD
Pomalidomide—PTGS2—Metabolism—MLXIPL—metabolic syndrome X	6.03e-05	0.000485	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—EPHX2—metabolic syndrome X	6.03e-05	0.000485	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	6.03e-05	0.000484	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	5.94e-05	0.000477	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IL6—metabolic syndrome X	5.9e-05	0.000473	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	5.89e-05	0.000473	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	5.81e-05	0.000467	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TNF—metabolic syndrome X	5.78e-05	0.000464	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—G6PC2—metabolic syndrome X	5.67e-05	0.000456	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TNF—metabolic syndrome X	5.65e-05	0.000453	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—PPARG—metabolic syndrome X	5.6e-05	0.000449	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—AKT1—metabolic syndrome X	5.59e-05	0.000449	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—INS—metabolic syndrome X	5.49e-05	0.000441	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	5.39e-05	0.000433	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—AKT1—metabolic syndrome X	5.24e-05	0.000421	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	5.22e-05	0.00042	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	5.06e-05	0.000406	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	4.98e-05	0.0004	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	4.94e-05	0.000397	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—G6PD—metabolic syndrome X	4.87e-05	0.000391	CbGpPWpGaD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—AKT1—metabolic syndrome X	4.85e-05	0.00039	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—FABP4—metabolic syndrome X	4.82e-05	0.000387	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—FMO3—metabolic syndrome X	4.8e-05	0.000385	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	4.79e-05	0.000384	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HDAC3—metabolic syndrome X	4.75e-05	0.000381	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	4.74e-05	0.00038	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	4.73e-05	0.00038	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—GCK—metabolic syndrome X	4.68e-05	0.000375	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL6—metabolic syndrome X	4.66e-05	0.000374	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—GCKR—metabolic syndrome X	4.64e-05	0.000373	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HSD11B1—metabolic syndrome X	4.57e-05	0.000367	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	4.51e-05	0.000362	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	4.43e-05	0.000356	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	4.4e-05	0.000354	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	4.31e-05	0.000346	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MLXIPL—metabolic syndrome X	4.28e-05	0.000344	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—EPHX2—metabolic syndrome X	4.28e-05	0.000344	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	4.23e-05	0.00034	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	4.21e-05	0.000338	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—RBP4—metabolic syndrome X	4.14e-05	0.000332	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TRIB3—metabolic syndrome X	4.14e-05	0.000332	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	4.13e-05	0.000331	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—G6PD—metabolic syndrome X	4.08e-05	0.000327	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	4.02e-05	0.000323	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—G6PC2—metabolic syndrome X	4.02e-05	0.000323	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HDAC3—metabolic syndrome X	3.98e-05	0.000319	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	3.93e-05	0.000316	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	3.93e-05	0.000315	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	3.9e-05	0.000313	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GCKR—metabolic syndrome X	3.89e-05	0.000312	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—LPA—metabolic syndrome X	3.89e-05	0.000312	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—FMO3—metabolic syndrome X	3.83e-05	0.000308	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	3.79e-05	0.000304	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PLA2G6—metabolic syndrome X	3.77e-05	0.000302	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	3.74e-05	0.0003	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOA5—metabolic syndrome X	3.73e-05	0.000299	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NAMPT—metabolic syndrome X	3.71e-05	0.000298	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—GCK—metabolic syndrome X	3.69e-05	0.000296	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOC3—metabolic syndrome X	3.67e-05	0.000294	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	3.64e-05	0.000292	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	3.63e-05	0.000291	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	3.62e-05	0.000291	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	3.55e-05	0.000285	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	3.52e-05	0.000283	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	3.51e-05	0.000282	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—TRIB3—metabolic syndrome X	3.47e-05	0.000278	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	3.42e-05	0.000275	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—FABP4—metabolic syndrome X	3.42e-05	0.000275	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—EPHX2—metabolic syndrome X	3.41e-05	0.000274	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MLXIPL—metabolic syndrome X	3.41e-05	0.000274	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HMGA1—metabolic syndrome X	3.37e-05	0.000271	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	3.24e-05	0.00026	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—GOT2—metabolic syndrome X	3.22e-05	0.000258	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—G6PC2—metabolic syndrome X	3.21e-05	0.000258	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CYBA—metabolic syndrome X	3.2e-05	0.000257	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—TGFB1—metabolic syndrome X	3.18e-05	0.000256	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NAMPT—metabolic syndrome X	3.11e-05	0.00025	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	3.09e-05	0.000248	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GCK—metabolic syndrome X	3.09e-05	0.000248	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—LIPC—metabolic syndrome X	3.09e-05	0.000248	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOC3—metabolic syndrome X	3.07e-05	0.000247	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	3.05e-05	0.000245	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	2.99e-05	0.00024	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	2.98e-05	0.00024	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CETP—metabolic syndrome X	2.98e-05	0.000239	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—FMO3—metabolic syndrome X	2.96e-05	0.000237	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	2.96e-05	0.000237	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	2.93e-05	0.000235	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—G6PD—metabolic syndrome X	2.89e-05	0.000232	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SLC2A4—metabolic syndrome X	2.87e-05	0.00023	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SCARB1—metabolic syndrome X	2.85e-05	0.000229	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HDAC3—metabolic syndrome X	2.82e-05	0.000226	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	2.79e-05	0.000224	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	2.78e-05	0.000223	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—GOT1—metabolic syndrome X	2.78e-05	0.000223	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SREBF1—metabolic syndrome X	2.77e-05	0.000223	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GCKR—metabolic syndrome X	2.76e-05	0.000221	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LPA—metabolic syndrome X	2.76e-05	0.000221	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—FABP4—metabolic syndrome X	2.73e-05	0.000219	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HMGCR—metabolic syndrome X	2.7e-05	0.000216	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GOT2—metabolic syndrome X	2.7e-05	0.000216	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	2.67e-05	0.000214	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOA5—metabolic syndrome X	2.64e-05	0.000212	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	2.64e-05	0.000212	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	2.64e-05	0.000212	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HSD11B1—metabolic syndrome X	2.59e-05	0.000208	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	2.52e-05	0.000202	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	2.51e-05	0.000201	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	2.48e-05	0.000199	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—TRIB3—metabolic syndrome X	2.46e-05	0.000197	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	2.44e-05	0.000196	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ABCA1—metabolic syndrome X	2.4e-05	0.000193	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SLC2A4—metabolic syndrome X	2.4e-05	0.000193	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—IL6—metabolic syndrome X	2.4e-05	0.000193	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	2.4e-05	0.000192	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	2.36e-05	0.00019	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOB—metabolic syndrome X	2.36e-05	0.000189	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GOT1—metabolic syndrome X	2.33e-05	0.000187	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GGT1—metabolic syndrome X	2.33e-05	0.000187	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—G6PD—metabolic syndrome X	2.31e-05	0.000185	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	2.28e-05	0.000183	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HDAC3—metabolic syndrome X	2.25e-05	0.000181	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—LPL—metabolic syndrome X	2.25e-05	0.000181	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—AKT1—metabolic syndrome X	2.21e-05	0.000178	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NAMPT—metabolic syndrome X	2.2e-05	0.000177	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GCKR—metabolic syndrome X	2.2e-05	0.000177	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LPA—metabolic syndrome X	2.2e-05	0.000177	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LIPC—metabolic syndrome X	2.19e-05	0.000176	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GCK—metabolic syndrome X	2.19e-05	0.000176	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOC3—metabolic syndrome X	2.18e-05	0.000175	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PLA2G6—metabolic syndrome X	2.13e-05	0.000171	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	2.12e-05	0.00017	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CETP—metabolic syndrome X	2.11e-05	0.00017	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOA5—metabolic syndrome X	2.11e-05	0.000169	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—FABP4—metabolic syndrome X	2.11e-05	0.000169	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	2.07e-05	0.000167	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	2.05e-05	0.000165	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SCARB1—metabolic syndrome X	2.02e-05	0.000162	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	2.01e-05	0.000161	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	2e-05	0.00016	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	1.98e-05	0.000159	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOB—metabolic syndrome X	1.97e-05	0.000159	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SREBF1—metabolic syndrome X	1.96e-05	0.000158	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—TRIB3—metabolic syndrome X	1.96e-05	0.000158	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PLA2G4A—metabolic syndrome X	1.92e-05	0.000154	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HMGCR—metabolic syndrome X	1.91e-05	0.000153	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GOT2—metabolic syndrome X	1.91e-05	0.000153	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOE—metabolic syndrome X	1.89e-05	0.000152	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—LPL—metabolic syndrome X	1.89e-05	0.000151	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	1.87e-05	0.00015	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOA1—metabolic syndrome X	1.87e-05	0.00015	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CD36—metabolic syndrome X	1.79e-05	0.000144	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—G6PD—metabolic syndrome X	1.78e-05	0.000143	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	1.76e-05	0.000141	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.75e-05	0.00014	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LIPC—metabolic syndrome X	1.75e-05	0.00014	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GCK—metabolic syndrome X	1.75e-05	0.00014	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	1.74e-05	0.00014	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOC3—metabolic syndrome X	1.74e-05	0.00014	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ABCA1—metabolic syndrome X	1.7e-05	0.000137	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	1.7e-05	0.000137	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LPA—metabolic syndrome X	1.7e-05	0.000136	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GCKR—metabolic syndrome X	1.7e-05	0.000136	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CETP—metabolic syndrome X	1.69e-05	0.000135	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IRS1—metabolic syndrome X	1.68e-05	0.000135	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPARA—metabolic syndrome X	1.67e-05	0.000134	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GOT1—metabolic syndrome X	1.65e-05	0.000132	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GGT1—metabolic syndrome X	1.65e-05	0.000132	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	1.64e-05	0.000132	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOA5—metabolic syndrome X	1.63e-05	0.000131	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	1.62e-05	0.00013	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AGT—metabolic syndrome X	1.61e-05	0.00013	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—INS—metabolic syndrome X	1.61e-05	0.000129	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOE—metabolic syndrome X	1.58e-05	0.000127	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.57e-05	0.000126	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	1.57e-05	0.000126	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOA1—metabolic syndrome X	1.56e-05	0.000125	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	1.53e-05	0.000122	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GOT2—metabolic syndrome X	1.53e-05	0.000122	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	1.51e-05	0.000122	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SERPINE1—metabolic syndrome X	1.48e-05	0.000119	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS3—metabolic syndrome X	1.41e-05	0.000114	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOB—metabolic syndrome X	1.4e-05	0.000112	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPARG—metabolic syndrome X	1.38e-05	0.000111	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.38e-05	0.00011	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	1.36e-05	0.000109	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	1.36e-05	0.000109	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	1.36e-05	0.000109	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	1.36e-05	0.000109	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—INS—metabolic syndrome X	1.35e-05	0.000108	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LIPC—metabolic syndrome X	1.35e-05	0.000108	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GCK—metabolic syndrome X	1.35e-05	0.000108	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOC3—metabolic syndrome X	1.34e-05	0.000108	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LPL—metabolic syndrome X	1.34e-05	0.000107	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GGT1—metabolic syndrome X	1.32e-05	0.000106	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GOT1—metabolic syndrome X	1.32e-05	0.000106	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CETP—metabolic syndrome X	1.3e-05	0.000105	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CD36—metabolic syndrome X	1.27e-05	0.000102	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	1.25e-05	0.0001	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALB—metabolic syndrome X	1.24e-05	9.94e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	1.21e-05	9.72e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NOS3—metabolic syndrome X	1.18e-05	9.51e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPARA—metabolic syndrome X	1.18e-05	9.48e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GOT2—metabolic syndrome X	1.18e-05	9.45e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	1.18e-05	9.45e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AGT—metabolic syndrome X	1.14e-05	9.18e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOE—metabolic syndrome X	1.12e-05	8.99e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOB—metabolic syndrome X	1.12e-05	8.97e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOA1—metabolic syndrome X	1.11e-05	8.89e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	1.09e-05	8.73e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LPL—metabolic syndrome X	1.07e-05	8.57e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	1.05e-05	8.43e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	1.05e-05	8.43e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GOT1—metabolic syndrome X	1.02e-05	8.16e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GGT1—metabolic syndrome X	1.02e-05	8.16e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CD36—metabolic syndrome X	1.01e-05	8.14e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPARG—metabolic syndrome X	9.76e-06	7.83e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—INS—metabolic syndrome X	9.57e-06	7.68e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPARA—metabolic syndrome X	9.42e-06	7.57e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TGFB1—metabolic syndrome X	9.35e-06	7.51e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AGT—metabolic syndrome X	9.13e-06	7.33e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOE—metabolic syndrome X	8.94e-06	7.18e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOA1—metabolic syndrome X	8.84e-06	7.1e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALB—metabolic syndrome X	8.77e-06	7.04e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOB—metabolic syndrome X	8.62e-06	6.92e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NOS3—metabolic syndrome X	8.39e-06	6.74e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	8.39e-06	6.74e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LPL—metabolic syndrome X	8.23e-06	6.61e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CD36—metabolic syndrome X	7.82e-06	6.28e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPARG—metabolic syndrome X	7.79e-06	6.25e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS2—metabolic syndrome X	7.67e-06	6.16e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—INS—metabolic syndrome X	7.64e-06	6.13e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARA—metabolic syndrome X	7.27e-06	5.84e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AGT—metabolic syndrome X	7.04e-06	5.66e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6—metabolic syndrome X	7.04e-06	5.66e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALB—metabolic syndrome X	7e-06	5.62e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOE—metabolic syndrome X	6.9e-06	5.54e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOA1—metabolic syndrome X	6.82e-06	5.48e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NOS3—metabolic syndrome X	6.7e-06	5.38e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—AKT1—metabolic syndrome X	6.5e-06	5.22e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	6.13e-06	4.92e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARG—metabolic syndrome X	6.01e-06	4.83e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—INS—metabolic syndrome X	5.9e-06	4.73e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AKT1—metabolic syndrome X	5.44e-06	4.37e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALB—metabolic syndrome X	5.4e-06	4.34e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NOS3—metabolic syndrome X	5.17e-06	4.15e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	4.73e-06	3.8e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AKT1—metabolic syndrome X	3.86e-06	3.1e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AKT1—metabolic syndrome X	3.08e-06	2.47e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AKT1—metabolic syndrome X	2.38e-06	1.91e-05	CbGpPWpGaD
